ClinicalTrials.gg
CompletedNCT03384849OPTO-MRIUpdated Mar 9, 2026

Evaluation of an MRI-compatible Vital Signs Sensor System

An observational study in Anxiety, Claustrophobia and Hyperventilation, sponsored by Military Institute of Aviation Medicine. Completed at 1 site in Poland. Per ClinicalTrials.gov, last updated 2026-03-09.

Primary conditionHyperventilationRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Hyperventilation
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Hyperventilation.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Military Institute of Aviation Medicine · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
200
Sex
All
01

Study summary

This study is to determine the possibility of assessing the level of anxiety in MRI patients by means of the respiration rate (RR) and heart rate (HR) indicators acquired by a fiber-optic sensor system. The mean RR and/or HR values recorded at the beginning and the end of an MRI scanning will be referred to the State Trait Anxiety Inventory (STAI) scores completed before and after the MRI scanning, respectively.

Read the detailed description

The main purpose of the study is to determine the possibility of assessing the level of anxiety by means of the respiration curve and/or ballistocardiographic (BCG) signal acquired from MRI patients using a fiber-optic sensor system. In many patients, the MRI examination causes enormous stress due to limited space in the scanner, isolation during the examination and high noise levels. Usually, anxiety or stress triggers an increase in respiration rate (RR), leading to hyperventilation in extreme cases. There are also frequent cases of disturbances in heart rate (HR). Thus, the symptoms of claustrophobia can be detected by monitoring respiration activity and heart work.

The fiber-optic sensor system consists of a sensor mat, an interrogator and a personal computer (PC), and records respiratory and BCG signals in patients during MRI. The metal-free sensor mat is placed under the patient's back, does not pose a threat to the patient and has no influence over the quality of imaging. The interrogation module detects the optical signal including vital signs, and the PC with software developed for signal processing and visualization enable the MRI operator to monitor patient's RR and HR.

Up to 200 MRI patients in different age, weight, and gender will be participated in the study. They will be asked to complete the State Trait Anxiety Inventory (STAI) questionnaire in order to estimate anxiety level before and after the MRI scanning. Relations between the STAI X-1 scores and the mean RR and/or HR values recorded at the beginning and the end of the MRI scanning will be analyzed using descriptive statistic methods. The research scheme includes also the collection of the STAI X-2 scores before the MRI scanning. Finally, the values of the physiological parameters, which may indicate a dangerous level of anxiety will be determined. Positive results of the clinical evaluation will predestine the fiber-optic sensor system to be implemented in routine MRI procedures.

02

Conditions studied

  • Anxiety
  • Claustrophobia
  • Hyperventilation
  • Stress

Browse trials for

Keywords

  • Fiber-optic sensor system
  • Magnetic resonance imaging
  • Medical monitoring
  • Physiological parameters
03

In context

Hyperventilation Reclassified

43 studies on the registry are indexed under Hyperventilation; 6 are open to participants now.

This study's planned enrollment of 200 is above the median of 54 across 11 observational studies indexed under Hyperventilation.

Browse Hyperventilation studies →

Lead sponsor

Military Institute of Aviation Medicine is the lead sponsor of 3 studies on the registry; none are open to participants now.

Compared within Hyperventilation, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Up to 200 MRI patients of different age, weight and sex.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • MRI patients

Exclusion criteria

Exclusion Criteria:

  • Same as in MRI procedures
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • MRI patients

    Up to 200 patients of different age, weight and sex, which undergo MRI examinations.

    Diagnostic Test: MRI examination

Interventions

  • Diagnostic testMRI examination

    The part of the body that is being scanned and the time of the MRI examination are not relevant.

06

What researchers measure

Primary outcomes

  1. Optical signal

    Instantaneous spectral position of the fiber Bragg grating (FBG) reflection peak in nanometers that represents respiration curve and ballistocardiogram

    Time frame: 60 minutes

Secondary outcomes

  1. RR

    Respiration rate in respirations per minute

    Time frame: 60 minutes

  2. HR

    Heart rate in beats per minute

    Time frame: 60 minutes

Other outcomes

  1. RR_1

    Respiration rate at the beginning of the MRI scanning in respirations per minute

    Time frame: 2 minutes

  2. RR_2

    Respiration rate at the end of the MRI scanning in respirations per minute

    Time frame: 2 minutes

  3. HR_1

    Heart rate at the beginning of the MRI scanning in beats per minute

    Time frame: 2 minutes

  4. HR_2

    Heart rate at the end of the MRI scanning in beats per minute

    Time frame: 2 minutes

  5. STAI X-1_1

    STAI X-1 scores completed before the MRI scanning. Scale range: 20 - 80 (raw scores), where 20 means low anxiety, and 80 indicates high anxiety (the higher the result, the higher the level of anxiety).

    Time frame: 1 minute

  6. STAI X-1_2

    STAI X-1 scores completed after the MRI scanning. Scale range: 20 - 80 (raw scores), where 20 means low anxiety, and 80 indicates high anxiety (the higher the result, the higher the level of anxiety).

    Time frame: 1 minute

  7. STAI X-2

    STAI X-2 scores completed before the MRI scanning. Scale range: 20 - 80 (raw scores), where 20 means low anxiety, and 80 indicates high anxiety (the higher the result, the higher the level of anxiety).

    Time frame: 1 minute

07

Study locations

1 site
  • Military Institute of Aviation Medicine
    Warsaw, 01-755, Poland
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03384849
Lead sponsor
Military Institute of Aviation Medicine
Responsible party
Sponsor
First posted
Dec 27, 2017
Start date
Jan 3, 2017
Primary completion
Jul 31, 2019
Completion
Jul 31, 2019
Last update
Mar 9, 2026

Study contacts

Łukasz Dziuda, DSc, PhD
principal investigator · Military Institute of Aviation Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion